Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Promis Neurosciences (PMN) had Return on Investments of 16.85% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$2.78M |
|
-- |
|
-- |
|
$16.83M |
|
$-16.83M |
|
$19.61M |
|
$2.78M |
|
$2.78M |
|
$2.78M |
|
$2.78M |
|
$2.78M |
|
$2.78M |
|
$-16.83M |
|
$-16.83M |
|
25.92M |
|
26.46M |
|
$0.11 |
|
$0.11 |
|
| Balance Sheet Financials | |
$18.91M |
|
-- |
|
-- |
|
$18.91M |
|
$2.22M |
|
-- |
|
$0.20M |
|
$2.42M |
|
$16.49M |
|
$16.49M |
|
$16.49M |
|
32.69M |
|
| Cash Flow Statement Financials | |
$-27.18M |
|
$-0.00M |
|
$27.88M |
|
$12.60M |
|
$13.29M |
|
$0.69M |
|
$0.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-27.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
16.85% |
|
16.85% |
|
14.69% |
|
|
Return on Investments |
16.85% |
$0.50 |
|
$-1.03 |
|
$-1.03 |
|